204 related articles for article (PubMed ID: 28930286)
1. Molecular and cellular signatures underlying superior immunity against Bordetella pertussis upon pulmonary vaccination.
Raeven RH; Brummelman J; Pennings JLA; van der Maas L; Helm K; Tilstra W; van der Ark A; Sloots A; van der Ley P; van Eden W; Jiskoot W; van Riet E; van Els CA; Kersten GF; Han WG; Metz B
Mucosal Immunol; 2018 May; 11(3):979-993. PubMed ID: 28930286
[TBL] [Abstract][Full Text] [Related]
2. Intranasal immunization with outer membrane vesicle pertussis vaccine confers broad protection through mucosal IgA and Th17 responses.
Raeven RHM; Rockx-Brouwer D; Kanojia G; van der Maas L; Bindels THE; Ten Have R; van Riet E; Metz B; Kersten GFA
Sci Rep; 2020 Apr; 10(1):7396. PubMed ID: 32355188
[TBL] [Abstract][Full Text] [Related]
3. Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine.
Ross PJ; Sutton CE; Higgins S; Allen AC; Walsh K; Misiak A; Lavelle EC; McLoughlin RM; Mills KH
PLoS Pathog; 2013; 9(4):e1003264. PubMed ID: 23592988
[TBL] [Abstract][Full Text] [Related]
4. Sustained protective immunity against Bordetella pertussis nasal colonization by intranasal immunization with a vaccine-adjuvant combination that induces IL-17-secreting T
Allen AC; Wilk MM; Misiak A; Borkner L; Murphy D; Mills KHG
Mucosal Immunol; 2018 Nov; 11(6):1763-1776. PubMed ID: 30127384
[TBL] [Abstract][Full Text] [Related]
5. Development of a thermostable spray dried outer membrane vesicle pertussis vaccine for pulmonary immunization.
Kanojia G; Raeven RHM; van der Maas L; Bindels THE; van Riet E; Metz B; Soema PC; Ten Have R; Frijlink HW; Amorij JP; Kersten GFA
J Control Release; 2018 Sep; 286():167-178. PubMed ID: 30048656
[TBL] [Abstract][Full Text] [Related]
6. A novel TLR2 agonist from Bordetella pertussis is a potent adjuvant that promotes protective immunity with an acellular pertussis vaccine.
Dunne A; Mielke LA; Allen AC; Sutton CE; Higgs R; Cunningham CC; Higgins SC; Mills KH
Mucosal Immunol; 2015 May; 8(3):607-17. PubMed ID: 25315966
[TBL] [Abstract][Full Text] [Related]
7. Pertussis vaccines and protective immunity.
Kapil P; Merkel TJ
Curr Opin Immunol; 2019 Aug; 59():72-78. PubMed ID: 31078081
[TBL] [Abstract][Full Text] [Related]
8. Immunological Signatures after Bordetella pertussis Infection Demonstrate Importance of Pulmonary Innate Immune Cells.
Raeven RH; Brummelman J; van der Maas L; Tilstra W; Pennings JL; Han WG; van Els CA; van Riet E; Kersten GF; Metz B
PLoS One; 2016; 11(10):e0164027. PubMed ID: 27711188
[TBL] [Abstract][Full Text] [Related]
9. Molecular signatures of the evolving immune response in mice following a Bordetella pertussis infection.
Raeven RH; Brummelman J; Pennings JL; Nijst OE; Kuipers B; Blok LE; Helm K; van Riet E; Jiskoot W; van Els CA; Han WG; Kersten GF; Metz B
PLoS One; 2014; 9(8):e104548. PubMed ID: 25137043
[TBL] [Abstract][Full Text] [Related]
10. Immunity to the respiratory pathogen Bordetella pertussis.
Higgs R; Higgins SC; Ross PJ; Mills KH
Mucosal Immunol; 2012 Sep; 5(5):485-500. PubMed ID: 22718262
[TBL] [Abstract][Full Text] [Related]
11. Meta-Analysis of Pulmonary Transcriptomes from Differently Primed Mice Identifies Molecular Signatures to Differentiate Immune Responses following
Raeven RH; Pennings JL; van Riet E; Kersten GF; Metz B
J Immunol Res; 2017; 2017():8512847. PubMed ID: 28243609
[TBL] [Abstract][Full Text] [Related]
12. Azithromycin Clears
Borkner L; Misiak A; Wilk MM; Mills KHG
Front Immunol; 2018; 9():1764. PubMed ID: 30105030
[TBL] [Abstract][Full Text] [Related]
13. The role of Toll-like receptor-4 in pertussis vaccine-induced immunity.
Banus S; Stenger RM; Gremmer ER; Dormans JA; Mooi FR; Kimman TG; Vandebriel RJ
BMC Immunol; 2008 May; 9():21. PubMed ID: 18498620
[TBL] [Abstract][Full Text] [Related]
14. Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles.
Cahill ES; O'Hagan DT; Illum L; Barnard A; Mills KH; Redhead K
Vaccine; 1995 Apr; 13(5):455-62. PubMed ID: 7639014
[TBL] [Abstract][Full Text] [Related]
15. Bordetella pertussis infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primates.
Warfel JM; Merkel TJ
Mucosal Immunol; 2013 Jul; 6(4):787-96. PubMed ID: 23187316
[TBL] [Abstract][Full Text] [Related]
16. Heterologous prime-boost immunization with live attenuated B. pertussis BPZE1 followed by acellular pertussis vaccine in mice.
Feunou PF; Kammoun H; Debrie AS; Locht C
Vaccine; 2014 Jul; 32(34):4281-8. PubMed ID: 24950361
[TBL] [Abstract][Full Text] [Related]
17. Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity.
Redhead K; Watkins J; Barnard A; Mills KH
Infect Immun; 1993 Aug; 61(8):3190-8. PubMed ID: 8335349
[TBL] [Abstract][Full Text] [Related]
18. Mutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cells.
Ryan EJ; McNeela E; Murphy GA; Stewart H; O'hagan D; Pizza M; Rappuoli R; Mills KH
Infect Immun; 1999 Dec; 67(12):6270-80. PubMed ID: 10569737
[TBL] [Abstract][Full Text] [Related]
19. Outer membrane vesicles: an attractive candidate for pertussis vaccines.
Hozbor DF
Expert Rev Vaccines; 2017 Mar; 16(3):193-196. PubMed ID: 28010142
[No Abstract] [Full Text] [Related]
20. Intranasal Immunization With a c-di-GMP-Adjuvanted Acellular Pertussis Vaccine Provides Superior Immunity Against
Jiang W; Wang X; Su Y; Cai L; Li J; Liang J; Gu Q; Sun M; Shi L
Front Immunol; 2022; 13():878832. PubMed ID: 35493458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
